Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acceptability of Identifying and Managing Psychological Distress in Inflammatory Bowel Disease: the COMPASS-IBD Study

NCT05330299 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

NCT NCT05330299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05330299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acceptability of Identifying and Managing Psychological Distress in Inflammatory Bowel Disease: the COMPASS-IBD Study
Lead sponsor
King's College London
Phase
Not applicable
Overall status
Unknown status
Start date
December 2, 2022
Completion date
February 29, 2024
Enrollment
108 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ibd, psychological distress, treatment of illness-related distress in ibd